about
The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agentsPoxvirus vectors as HIV/AIDS vaccines in humansPoxvirus tropismImmunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats.Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.Viral and nonviral delivery systems for gene deliveryTaking advantage of the positive side-effects of smallpox vaccination.Progress toward an elusive goal: current status of cytomegalovirus vaccines.Sustained protective rabies neutralizing antibody titers after administration of cationic lipid-formulated pDNA vaccine.Viral vector-based therapeutic cancer vaccinesCancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.Lentiviral vectors for immunization: an inflammatory field.Innate immune recognition of poxviral vaccine vectors.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Immunogenicity of the capsid precursor and a nine-amino-acid site-directed mutant of the 3C protease of foot-and-mouth disease virus coexpressed by a recombinant goatpox virus.Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.
P2860
Q24804488-8C2C6B41-CF30-4186-8D8B-CB0544327F74Q26995078-B63FC79E-938D-40BD-8CFD-8C7212DBAFF2Q28237434-65842CDC-0E2B-4C01-B893-C9EA4F883854Q33226785-3F4DD537-B6AE-421A-8722-793D268A0459Q33838507-3BC76592-45E7-4DB3-9F6B-A30359301A22Q34017475-F23D19C9-5741-4EDF-81B6-EC88FC998470Q34315475-A91E5992-3A19-4F97-B7EE-896C323F9152Q34343505-A1EC514F-DE84-41D0-B098-A3C29CAB34AAQ34434818-EA033735-4AC6-4CE4-A604-DD97990B76B5Q34521758-F9E34EB2-12CD-4D6F-BA4C-FDB3F40E633BQ35515080-6EBE209B-8F40-4F08-8CA1-A573BBF84136Q36689038-32CD7BFC-C1B1-44E9-9CE6-E4A9ACD42958Q36849770-36240A4C-C71C-4BEA-B5DC-2C4FB51FD25EQ37706590-1477E745-CEEC-4F43-9F54-0FC1D1FB0898Q37944321-31105937-9D12-4C3E-B788-DB22C5A07E10Q38748193-69EC2E30-5447-44A0-86B5-08C8F27B745BQ42240435-C0A8BB46-85DD-4C80-93F5-14458ED596D7Q44740296-33EAD630-CF50-4B41-8DE3-074BA876C4E9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Poxviruses as vaccine vectors.
@ast
Poxviruses as vaccine vectors.
@en
type
label
Poxviruses as vaccine vectors.
@ast
Poxviruses as vaccine vectors.
@en
prefLabel
Poxviruses as vaccine vectors.
@ast
Poxviruses as vaccine vectors.
@en
P1476
Poxviruses as vaccine vectors.
@en
P2093
Pastoret PP
Vanderplasschen A
P304
P356
10.1016/S0147-9571(03)00019-5
P577
2003-10-01T00:00:00Z